Literature DB >> 11484414

Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats.

J O Kang1, S J Kim, H Kim.   

Abstract

Astaxanthin is one of many carotenoids present in marine animals, vegetables and fruits. Since carotenoids are known to have antioxidant properties, we tested to determine if astaxanthin could have protective effects in the CCl4-treated rat liver by activating the antioxidant system. Astaxanthin blocked the increase of glutamate-oxalacetate transaminase (GOT) and glutamate-pyruvate transaminase (GTP) activity and thiobarbituric acid reactive substances (TBARS) in response to carbon tetrachloride (CCl4), while causing an increase in glutathione (GSH) levels and superoxide dismutase (SOD) activities in the CCl4-treated rat liver. These results suggest that astaxanthin protects liver damage induced by CCl4 by inhibiting lipid peroxidation and stimulating the cellular antioxidant system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484414     DOI: 10.1358/mf.2001.23.2.627931

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  15 in total

1.  Evaluation of hepatoprotective and antioxidant activity of astaxanthin and astaxanthin esters from microalga-Haematococcus pluvialis.

Authors:  A Ranga Rao; R Sarada; M D Shylaja; G A Ravishankar
Journal:  J Food Sci Technol       Date:  2015-03-05       Impact factor: 2.701

2.  Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.

Authors:  Yuqing Yang; Francisco Fuentes; Limin Shu; Chao Wang; Doug Pung; Wenji Li; Chengyue Zhang; Yue Guo; Ah-Ng Kong
Journal:  AAPS J       Date:  2016-12-02       Impact factor: 4.009

3.  Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells.

Authors:  Yuqing Yang; Irene Yang; Mingnan Cao; Zheng-Yuan Su; Renyi Wu; Yue Guo; Mingzhu Fang; Ah-Ng Kong
Journal:  AAPS J       Date:  2018-02-20       Impact factor: 4.009

Review 4.  Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Authors:  Robert G Fassett; Jeff S Coombes
Journal:  Mar Drugs       Date:  2011-03-21       Impact factor: 5.118

5.  Antihypertensive effects of astaxanthin.

Authors:  Hidekatsu Yanai; Kumie Ito; Hiroshi Yoshida; Norio Tada
Journal:  Integr Blood Press Control       Date:  2008-10-27

6.  Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.

Authors:  Miao Shen; Kan Chen; Jie Lu; Ping Cheng; Ling Xu; Weiqi Dai; Fan Wang; Lei He; Yan Zhang; Wang Chengfen; Jingjing Li; Jing Yang; Rong Zhu; Huawei Zhang; Yuanyuan Zheng; Yingqun Zhou; Chuanyong Guo
Journal:  Mediators Inflamm       Date:  2014-04-17       Impact factor: 4.711

7.  Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis.

Authors:  Reiko Yamagishi; Makoto Aihara
Journal:  Mol Vis       Date:  2014-12-31       Impact factor: 2.367

8.  Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.

Authors:  Yinhua Ni; Mayumi Nagashimada; Fen Zhuge; Lili Zhan; Naoto Nagata; Akemi Tsutsui; Yasuni Nakanuma; Shuichi Kaneko; Tsuguhito Ota
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

Review 9.  Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.

Authors:  Yinhua Ni; Fen Zhuge; Mayumi Nagashimada; Tsuguhito Ota
Journal:  Nutrients       Date:  2016-06-24       Impact factor: 5.717

Review 10.  Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.

Authors:  Guanliang Chen; Yinhua Ni; Naoto Nagata; Liang Xu; Tsuguhito Ota
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.